Gut-brain connections in neurodegenerative disease: immunotherapeutic targeting of Bin1 in inflammatory bowel disease and Alzheimer’s disease
Longer lifespan produces risks of age-associated neurodegenerative disorders such as Alzheimer’s disease (AD), which is characterized by declines in memory and cognitive function. The pathogenic causes of AD are thought to reflect a progressive aggregation in the brain of amyloid plaques composed of...
Main Authors: | Sunil Thomas, George C. Prendergast |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-07-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2023.1183932/full |
Similar Items
-
Gut Microbiota and Immunotherapy for Alzheimer’s Disease
by: Chun-Ling Dai, et al.
Published: (2022-12-01) -
The Risk of Developing Alzheimer’s Disease and Parkinson’s Disease in Patients with Inflammatory Bowel Disease: A Meta-Analysis
by: Marta Szandruk-Bender, et al.
Published: (2022-06-01) -
Increased neutrophils in inflammatory bowel disease accelerate the accumulation of amyloid plaques in the mouse model of Alzheimer’s disease
by: Ryusei Kaneko, et al.
Published: (2023-03-01) -
Effects of gut microbiota on neurodegenerative diseases
by: Saima Khatoon, et al.
Published: (2023-05-01) -
Gut Microbiota Regulation and Their Implication in the Development of Neurodegenerative Disease
by: Peilin Sun, et al.
Published: (2021-11-01)